Overview

Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in COPD

Status:
Completed
Trial end date:
2004-04-01
Target enrollment:
Participant gender:
Summary
Non-inferiority of lung function response to Tiotropium inhalation solution compared to Spiriva HandiHaler
Phase:
Phase 3
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Tiotropium Bromide